Cryosite Limited (ASX:CTE)
Share Pricing & News Healthcare

AUD 0.75

0 (0%)
(As on 2022-12-02 08:05:46 AEDT)
Previous Close Open Close*
0.75 0.75 0.75
Market Cap Dividend Yield (Annualized)
AUD 36.607M 1.59%

Day Range
0.75L 0.75 H
0.34L 0.87 H

Chart Price & Information

Last Trade 0.75
Change% 0.0000
52 W H/L 0.870/0.340
NPAT After Abnormal Items 1.364M
Equity 1.861M
ROE% 73.29%
Total Liabilities 19.642M
Total Revenue 11.757M
Cash and Cash Equivalents 5.341M

Stock Information

Share price 0.75
Market Cap 36.607M
Price/Gross Cash Flow 16.35
Dividend Yield Excluding Special 1.59%
Ending Shares 48.81M
52-Week Range 0.870-0.340
Gross DPS (AUD) 0.01
Gross Dividend Yield (Annualized) 1.59%
Earnings Yield 3.720
Net Tangible Asset (NTA) 0.04
P/E ratio 26.882
Sector P/E --
EPS 2.79
Net Profit Margin (%) 11.60%
Gross Cash Flows Per Share 0.04
Net Gearing -241.34%
Sales Per Share 0.24
Book Value Per Share 0.04

Similar Companies

Related Articles

About Company

Listed on the ASX since 2002, Cryosite Limited (ASX: CTE) is an Australian biotech and biologics logistics company. CTE specialises in Clinical Trial Logistics and all temperature storage. The two core business lines of the company include of- Cord Blood & Tissues Storage and Clinical Trials Logistics & Biorepository. CTE is headquartered in New South Wales and was founded in 1999.

Corporate Information

13A Ferndell Street,, SOUTH GRANVILLE, NSW, AUSTRALIA, 2142




Ex-Date Net Dividend Frank Flag Period End Date Type Payable

Event Calendar

Event Type Event Date Event Year
Report (Annual) 2023-08-25 2023
Report (Prelim) 2023-08-25 2023
Report (Interim) 2023-02-22 2023